4.7 Review

Reproducibility of food challenge to cow's milk: Systematic review with individual participant data meta-analysis

Journal

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 150, Issue 5, Pages 1135-+

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2022.04.035

Keywords

Allergy; anaphylaxis; cow's milk; eliciting dose; food challenge; thresholds; precautionary allergen labeling

Funding

  1. UK Medical Research Council Clinician Scientist award [MR/K010468/1]
  2. National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare National Health Service (NHS) Trust
  3. Imperial College London

Ask authors/readers for more resources

Cow's milk is a common cause of severe allergic reactions, but the severity of reactions at low-level exposure and the reproducibility of reaction thresholds are uncertain. This study found that about 5% of individuals with allergic reactions to low-level cow's milk protein may experience anaphylaxis. Most of these anaphylactic reactions are mild and can be treated with a single dose of epinephrine.
Background: Cow's milk (CM) is an increasingly common cause of severe allergic reactions, but there is uncertainty with respect to severity of reactions at low-level CM exposure, as well as the reproducibility of reaction thresholds. Objective: We undertook an individual participant data (IPD) meta-analysis of studies reporting double-blind, placebo-controlled food challenges in CM to determine the rate of anaphylaxis to low-level exposures and the reproducibility of reaction thresholds. Methods: We performed a systematic review and IPD meta -analysis of studies reporting relevant data. Authors were contacted to provide additional data and/or clarification as needed. Risk of bias was assessed using the National Institute for Clinical Excellence methodologic checklists. Results: Thirty-four studies were included, representing data from over 1000 participants. The cumulative ED01 and ED05 (cumulative doses causing objective symptoms in 1% and 5% of the at-risk allergic population) were 0.3 (95% confidence interval [CI], 0.2-0.5) and 2.9 (95% CI, 1.6-5.4) mg, respectively. At meta-analysis, 4.8% (95% CI, 2.0-10.9) and 4.8% (95% CI, 0.7-27.1) of individuals reacting to <_5 mg and <_0.5 mg of CM protein had anaphylaxis (minimal heterogeneity, I2 5 0%). Then 110 individuals underwent repeat double-blind, placebo -controlled food challenges; the intraindividual variation in reaction threshold was limited to a 1/2-log change in 80% (95% CI, 65-89) of participants. Two individuals initially tolerated 5 mg CM protein but then reacted to this dose at a subsequent challenge, although neither had anaphylaxis. Conclusions: About 5% of CM-allergic individuals reacting to ED01 or ED05 exposure might have anaphylaxis to that dose. This equates to 5 and 24 anaphylaxis events per 10,000 patients exposed to an ED01 or ED05 dose, respectively, in the broader CM-allergic population. Most of these anaphylactic reactions would be mild and respond to a single dose of epinephrine. (J Allergy Clin Immunol 2022;150:1135-43.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available